← Leaderboards
Frank G. Ondrey
University Of Minnesota
$1,900,461
Attributed
$1,900,461
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $784.5K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,900,461 · 2
By mechanism
R01$1,658,101 · 1
P30$242,360 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Jiehong Guo$155,000
- Lisa A Peterson$17,276,249
- Fekadu Kassie$5,236,992
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsCarcinogenesisMalignant NeoplasmsPreventChemopreventionCancer PreventionClinical ChemopreventionFundingPrevention StrategyTobaccoCohortHealthcareBasic ScienceBaseAwardAreaCancer RiskCarcinogenesis MechanismBudgetsCancer CenterBiometryBurden Of IllnessCancer BiomarkersAnalytical Biochemistry
Grant awards (9)
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia$784,472
R01 · FY2025 · CA · contact PI
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia$103,823
R01 · FY2024 · CA · contact PI
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia$448,240
R01 · FY2023 · CA · contact PI
Carcinogenesis and Chemoprevention$48,472
P30 · FY2023 · CA · contact PI
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia$321,566
R01 · FY2022 · CA · contact PI
Carcinogenesis and Chemoprevention$48,472
P30 · FY2022 · CA · contact PI
Carcinogenesis and Chemoprevention$48,472
P30 · FY2021 · CA · contact PI
Carcinogenesis and Chemoprevention$48,472
P30 · FY2020 · CA · contact PI
Carcinogenesis and Chemoprevention$48,472
P30 · FY2019 · CA · contact PI